Skip to main content

Advertisement

SpringerLink
Log in

Relation of Matrix Metalloproteinase-9 to Different Stages of Tumors in the Serum of Gastric Cancer

  • ORIGINAL ARTICLE
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

The sera of 40 patients with gastric cancer and 11 patients as the control group were studied for the detection of matrix metalloproteinases. The malignant behavior of tumor cells mainly depends on the capability of invasion and the metastasis of cancer cells. After the components of the extracellular matrix (ECM) are degraded, tumor cells invade the surrounding tissue and the vascular or lymphatic vessels to form metastasis colonies at distant sites. Extracellular proteolytic enzymes implicate the invasion and metastasis of cancer. Proteolytic enzymes from tumors lead to the breakdown of basement membranes and the ECM, thereby, facilitating cancer cell invasion into the surrounding normal tissue. Proteinase activity is overexpressed in the serum of stage 3 and 4 tumors compared to stage 1 and 2 tumors. ProMMP-9 was detected in the serum of patients of gastric cancer by SDS polyacrylamide gel electrophoresis (SDS-PAGE) and SDS-PAGE zymography, with its molecular mass of 92 kDa. MMP-9 in serum plays an important role in the progression of gastric cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Itoh T, Tanioka M, Yoshida H, Yoshioka T, Nishimoto H, Itohara S. Reduced angiogenesis and tumor progression in gelatinase A––deficient mice. Cancer Res. 1998;58:1048–1051.

    PubMed  CAS  Google Scholar 

  2. Liotta LA. Tumor invasion and metastases: role of the extracellular matrix: Rhoads memorial award lecture. Cancer Res. 1986;46:1–7. doi:10.1016/S0065-230X(08)60034-2.

    Article  PubMed  CAS  Google Scholar 

  3. Liotta LA, Tryggvason K, Garbis S, Hart I, Foltz CM, Shafie S. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature. 1980;284:67–68. doi:10.1038/284067a0.

    Article  PubMed  CAS  Google Scholar 

  4. Mc Cawley LJ, Matrisian LM. Matrix metalloproteinases: multifunctional contributors to tumor progression. Mol Med Today. 2000;6(4):149–156. doi:10.1016/S1357-4310(00)01686-5.

    Article  CAS  Google Scholar 

  5. Zucker S, Lysik RM, Zarrabi MH, Moll U. M(r) 92,000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer. Cancer Res. 1993;53:140–146.

    PubMed  CAS  Google Scholar 

  6. Hoikkala S, Paakko P, Soini Y, Makitaro R, Kinnula V, Turpeenniemi-Hujanen T. Tissue MMP-2/TIMP-2-complex are better prognostic factors than serum MMP-2, MMP-9 or TIMP-1 in stage I-III lung carcinoma. Cancer Lett. 2005;236:125–132. doi:10.1016/j.canlet.2005.05.012.

    Article  PubMed  CAS  Google Scholar 

  7. Ruokolainen H, Paakko P, Turpeenniemi-Hujanen T. Serum matrix metalloproteinase-9 in head and neck squamous cell carcinoma is a prognostic marker. Int J Cancer. 2005;116:422–427. doi:10.1002/ijc.21092.

    Article  PubMed  CAS  Google Scholar 

  8. Shen KH, Chi CW, Lo SS, Kao HL, Lui WY, Wu CW. Serum matrix metalloproteinase-9 level associated with stromal reaction in patients with gastric cancer. Anticancer Res. 2000;20:1307–1310.

    PubMed  CAS  Google Scholar 

  9. Hayasaka A, Suzuki N, Fujimoto N, et al. Elevated plasma levels of matrix metalloproteinase-9 (92 kDa type IV collagenase/gelatinase B) in hepatocellular carcinoma. Hepatology. 1996;24:1058–1062. doi:10.1002/hep.510240513.

    Article  PubMed  CAS  Google Scholar 

  10. Endo K, Maehara Y, Baba H, et al. Elevated levels of serum and plasma metalloproteinases in patient with gastric cancer. Anticancer Res. 1997;17:2253–2255.

    PubMed  CAS  Google Scholar 

  11. Torii A, Kodera Y, Uesaka K, et al. Plasma concentration of matrix metalloproteinase 9 in gastric cancer. Br J Surg. 1997;84:133–136. doi:10.1002/bjs.1800840147.

    Article  PubMed  CAS  Google Scholar 

  12. Souza-Tarla CD, Uzuelli JA, Machado AA, Gerlach RF, Tanus-Santos JE. Methodological issues affecting the determination of plasma matrix metalloproteinase (MMP)-2 and MMP-9 activites. Clin Biochem. 2005;38(5):410–414. doi:10.1016/j.clinbiochem.2005.02.010.

    Article  PubMed  CAS  Google Scholar 

  13. Gerlach RF, Uzuelli JA, Souza-Tarla CD, Tanus-Santos JE. Effect of anticoagulants on the determination of plasma matrix metalloproteinase (MMP)-2 and MMP-9 activites. Anal Biochem. 2005;344(1):147–149. doi:10.1016/j.ab.2005.04.038.

    Article  PubMed  CAS  Google Scholar 

  14. Gerlach RF, Demacq C, Jung K, Tanus-Santos JE. Rapid separation of serum does not avoid artificially higher matrix metalloproteinase (MMP)-9 levels in serum versus plasma. Clin Biochem. 2007;40(1–2):119–123. doi:10.1016/j.clinbiochem.2006.10.007.

    Article  PubMed  CAS  Google Scholar 

  15. Manello F, Tanus-Santos JE, Meschiari CA, Tonti GA. Differences in both matrix metalloproteinase 9 concentration and zymographic profile between plasma and serum with clot activators are due to the presence of amorphous silica or silicate salts in blood collection devices. Anal Biochem. 2008;374:56–63. doi:10.1016/j.ab.2007.11.020.

    Article  CAS  Google Scholar 

  16. Ebeling W, Hennrich N, Klockow M, Metz H, Orth HD, Lang H. Protenase K from Tritirachium album. Eur J Biochem. 1974;47:91–97. doi:10.1111/j.1432-1033.1974.tb03671.x.

    Article  PubMed  CAS  Google Scholar 

  17. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680–685. doi:10.1038/227680a0.

    Article  PubMed  CAS  Google Scholar 

  18. Kleiner DE, Stetler-Stevenson WG. Quantative zymography detection of picogram quantities of gelatinases. Anal Biochem. 1994;218:325–329. doi:10.1006/abio.1994.1186.

    Article  PubMed  CAS  Google Scholar 

  19. Gornall AG, Bardawill CJ, David MM. Determination of serum proteins by means of the Biuret reaction. J Biol Chem. 1949;177:751–766.

    PubMed  CAS  Google Scholar 

  20. Aznovoorian S, Murphy AN, Stettler-Stevenson WG, Liotta LA. Molecular aspects of tumor cells invasion and metastasis. Cancer. 1993;71:1368–1383. doi :10.1002/1097-0142(19930215)71:4<1368::AID-CNCR2820710432>3.0.CO;2-L.

  21. Nagase H, Woessner JF Jr. Matrix metalloproteinases. J Biol Chem. 1999;274:21491–21494. doi:10.1074/jbc.274.31.21491.

    Article  PubMed  CAS  Google Scholar 

  22. Westermarck J, Kahari VM. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J. 1999;13:781–792.

    PubMed  CAS  Google Scholar 

  23. Ellenrieder V, Adler G, Gress TM. Invasion and metastasis in pancreatic cancer. Ann Oncol. 1999;10S:45–50.

    Google Scholar 

  24. Kallakury BV, Karikehalli S, Haholu A, Sheehan CE, Azumi N, Ross JS. Increased expression of matrix metalloproteinases 2 and tissue inhibitors of metalloproteinases 1 and 2 correlate with poor prognostic variables in renal cell carcinoma. Clin Cancer Res. 2001;7:3113–31199.

    PubMed  CAS  Google Scholar 

  25. Sier CF, Kubben FJ, Ganesh S, et al. Tissue levels of matrix metalloproteinases MMP-2 and MMP 9 are related to the overall survival of patients with gastric carcinoma. Br J Cancer. 1996;74:413–417.

    PubMed  CAS  Google Scholar 

  26. Kabashima A, Maehara Y, Kakeji Y, Baba H, Koga T, Sugimachi K. Clinicopathological features and overexpression of matrix metalloproteinases in intramucosal gastric carcinoma with lymph node metastasis. Clin Cancer Res. 2000;6:3581–3584.

    PubMed  CAS  Google Scholar 

  27. Paez Preda M, Ledda MF, Goldberg V, et al. High levels of matrix metalloproteinases regulate proliferation and hormone secretion in pituitary cells. J Clin Endocrinol Metab. 2000;85:263. doi:10.1210/jc.85.1.263.

    Article  Google Scholar 

  28. Kubben FJGM, Sier CFM, van Duijn W, et al. Matrix metalloproteinase-2 is a consistent prognostic factor in gastric cancer. Br J Cancer. 2006;94:1035–1040. doi:10.1038/sj.bjc.6603041.

    Article  PubMed  CAS  Google Scholar 

  29. Wu CY, Wu MS, Chiang EP, et al. Plasma matrix metalloproteinase-9 level is better than serum matrix metalloproteinase-9 level to predict gastric cancer evolution. Clin Cancer Res. 2007;13(7):2054–2060. doi:10.1158/1078-0432.CCR-06-2299.

    Article  PubMed  CAS  Google Scholar 

  30. Kattan MW. Judging new markers by their ability to improve predictive accuracy. J Natl Cancer Inst. 2003;95:634–635.

    Article  PubMed  CAS  Google Scholar 

  31. Kattan MW, Karpeh MS, Mazymdar M, Brennan MF. Postoperative nonogram for disease-specific survival after an RO resection for gastric cancer carcinoma. J Clin Oncol. 2003;21:3647–3650. doi:10.1200/JCO.2003.01.240.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Chemistry, School of Medicine, University of Belgrade, Višegradska 26, 11000, Belgrade, Serbia

    V. Dragutinović & L. Izrael-Živković

  2. Institute of Digestive Diseases, Center of Esophagogastric Surgery, Clinical Center of Serbia, Koste Todorovića 6, 11000, Belgrade, Serbia

    N. Radovanović

Authors
  1. V. Dragutinović
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. Izrael-Živković
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. N. Radovanović
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to V. Dragutinović.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dragutinović, V., Izrael-Živković, L. & Radovanović, N. Relation of Matrix Metalloproteinase-9 to Different Stages of Tumors in the Serum of Gastric Cancer. Dig Dis Sci 54, 1203–1207 (2009). https://doi.org/10.1007/s10620-008-0472-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-008-0472-y

Keywords

Search

Navigation